Since retiring as a Managing Director at Credit Suisse in 2003, Mr. Madden has written a dozen articles about a Dual Track system to achieve freedom of choice for late stage, not-yet-FDA-approved drugs. In 2007, the Heartland Institute published More Choices, Better Health: Free to Choose Experimental Drugs, a booklet that summarized his work and was distributed with foreign translations. Subsequent and more comprehensive work on this topic is presented in his latest book, Free To Choose Medicine: How Faster Access to New Drugs Would Save Countless Lives and End Needless Suffering.

Madden received a mechanical engineering degree, working as an engineer, and served in the US Army during the Vietnam War, after the war Madden shifted gears and earned an MBA at the University of California at Berkeley . After graduation, my first job was with a Chicago bank. Madden joined HOLT Value Associates in the early 1990s. HOLT commercialized the CFROI framework worldwide and was acquired by Credit Suisse in 2002. He began writing corporate finance articles which were published in the Journal of Applied Corporate Finance, Journal of Portfolio Management, Journal of Applied Finance, Wall Street Journal, Journal of Investing, and other business publications and In 1999 published his first book: CFROI Valuation: A Total System Approach to Valuing the Firm was published by Butterworth-Heinemann.

Related Links

Bart Madden Discusses His Latest Book

CFROI Valuation: A Total System Approach to Valuing the Firm

LearningWhatWorks.com